Dementia and Cognitive Impairment Research
Dementia and Cognitive Impairment Research is a research topic within Psychiatry and Mental health. Science Explorer counts 68k research works in it since 1950. 22.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, management, and impact of Alzheimer's disease, including its relationship with mild cognitive impairment, dementia, neuroimaging techniques, cognitive decline, biomarkers, aging, and the burden experienced by caregivers. It also explores the role of vascular risk factors and the potential benefits of cognitive training.
- Alzheimer's Disease
- Mild Cognitive Impairment
- Dementia
- Neuroimaging
- Cognitive Decline
- Biomarkers
- Aging
- Caregiver Burden
- Vascular Risk Factors
- Cognitive Training
- Research works
- 68k fractional, since 1950
- In the world top 10%
- 15k per year above
- Top-10% rate
- 22.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +39% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Dementia and Cognitive Impairment Research research?
By volume, the United States and China publish the most (6k and 2k works in 2022–2025).
By volume, 2022–2025
- 1 United States 6k works
- 2 China 2k works
- 3 United Kingdom 1.2k works
- 4 Canada 794 works
- 5 Australia 607 works
- 6 Japan 580 works
- 7 South Korea 551 works
- 8 India 504 works
- 9 Germany 499 works
- 10 Spain 454 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Dementia and Cognitive Impairment Research research?
By volume in 2022–2025, University College London publishes the most Dementia and Cognitive Impairment Research research, followed by University of California, San Francisco and Harvard University.
By volume, 2022–2025
- 1 University College London United Kingdom 120 works
- 2 University of California, San Francisco United States 118 works
- 3 Harvard University United States 108 works
- 4 University of Southern California United States 99 works
- 5 University of Pennsylvania United States 94 works
- 6 Washington University in St. Louis United States 94 works
- 7 University of Pittsburgh United States 90 works
- 8 University of Michigan United States 89 works
- 9 Massachusetts General Hospital United States 88 works
- 10 Johns Hopkins University United States 83 works
Who are the leading researchers in Dementia and Cognitive Impairment Research?
The most-cited researchers publishing on Dementia and Cognitive Impairment Research include Valery L. Feigin, Mika Kivimäki and Charles Wolfe.
- 1 Valery L. Feigin 7.9k citations
- 2 Mika Kivimäki 6.7k citations
- 3 Charles Wolfe 6k citations
- 4 Narayanaswamy Venketasubramanian 5.4k citations
- 5 Josef Coresh 5.3k citations
- 6 Luigi Ferrucci 5.3k citations
- 7 John C. Morris 5.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Dementia and Cognitive Impairment Research research done?
The largest centres of Dementia and Cognitive Impairment Research research in 2022–2025 are London (United Kingdom), Beijing (China), Seoul (South Korea) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Ōbu and Indianapolis.
Largest cities, 2022–2025
- 1 London United Kingdom 474 works
- 2 Beijing China 359 works
- 3 Seoul South Korea 301 works
- 4 Boston United States 291 works
- 5 New York United States 283 works
- 6 Shanghai China 239 works
- 7 San Francisco United States 211 works
- 8 Toronto Canada 184 works
- 9 Montreal Canada 180 works
- 10 Baltimore United States 180 works
Where it is the local speciality
- ŌbuJP · 24.5 works48×
- Indianapolis35.3 works13×
Location quotient: how much more of its research is in Dementia and Cognitive Impairment Research than the world average.
Where is the best place to study Dementia and Cognitive Impairment Research?
Among universities, judged by research, Duke-NUS Medical School, University of Southern California and University College London score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Duke-NUS Medical School Singapore | 66.1 | 27.2% | 12.1× | 15 | +248.4% |
| 2 | University of Southern California United States | 64.5 | 23.9% | 8.0× | 99 | +124.0% |
| 3 | University College London United Kingdom | 63.3 | 30.5% | 5.2× | 120 | +84.0% |
| 4 | University of California, San Francisco United States | 62.2 | 18.1% | 11.0× | 118 | +24.3% |
| 5 | Karolinska Institutet Sweden | 60.3 | 25.2% | 8.5× | 64 | -10.1% |
| 6 | Indiana University – Purdue University Indianapolis United States | 56.0 | 19.1% | 9.2× | 47 | +71.7% |
| 7 | Wake Forest University United States | 55.9 | 15.8% | 13.5× | 57 | +54.5% |
| 8 | Indiana University School of Medicine ?? | 55.6 | 17.7% | 13.1× | 35 | +82.2% |
| 9 | National University Health System Singapore | 55.4 | 30.7% | 9.9× | 11 | +34.5% |
| 10 | University Memory and Aging Center United States | 55.2 | 17.1% | 196.8× | 36 | +18.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Dementia and Cognitive Impairment Research research growing?
Output in 2018–2022 was 39% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Dementia and Cognitive Impairment Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.